China Regenerative Medicine International Limited (HKG:8158)

HKG:8158 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	110	90	167	317	799	1,627
Market Cap Growth	18.03%	-46.36%	-47.18%	-60.36%	-50.88%	789.56%
Enterprise Value	178	139	237	377	822	1,762
Last Close Price	0.36	0.29	0.55	1.11	2.80	5.70
PE Ratio	87.83	5.06	-	69.56	15.42	-
PS Ratio	1.88	0.99	2.41	7.63	2.83	8.93
PB Ratio	3.77	3.56	14.19	3.05	7.15	-29.50
P/TBV Ratio	3.77	3.56	14.19	3.05	7.15	27.99
P/FCF Ratio	46.51	5.08	15.91	-	-	-
P/OCF Ratio	36.73	4.90	15.51	-	-	-
EV/Sales Ratio	3.06	1.53	3.41	9.08	2.91	9.67
EV/EBITDA Ratio	-	20.41	-	31.49	13.33	-
EV/EBIT Ratio	-	22.62	-	31.94	13.34	-
EV/FCF Ratio	75.71	7.85	22.50	-	-	-
Debt / Equity Ratio	2.62	2.13	4.26	0.69	0.32	-0.78
Debt / EBITDA Ratio	-	3.14	-	4.19	0.58	-
Debt / FCF Ratio	32.29	3.04	4.77	-	-	-
Net Debt / Equity Ratio	2.37	1.23	3.97	0.68	0.23	-0.70
Net Debt / EBITDA Ratio	-2.42	4.56	-1.83	5.86	0.42	-9.44
Net Debt / FCF Ratio	29.20	1.75	4.46	-4.67	-6.76	-0.10
Asset Turnover	0.38	0.56	0.30	0.16	1.38	0.52
Inventory Turnover	75.05	96.81	136.97	11.68	244.23	34.58
Quick Ratio	0.78	0.87	1.09	1.52	1.41	0.61
Current Ratio	0.89	0.99	1.14	1.58	1.75	0.71
Return on Equity (ROE)	4.68%	95.98%	-186.16%	4.23%	183.20%	-
Return on Assets (ROA)	-11.96%	2.38%	-7.07%	2.76%	18.72%	-1.03%
Return on Invested Capital (ROIC)	-29.63%	10.69%	-22.44%	4.17%	82.19%	-8116.08%
Return on Capital Employed (ROCE)	-29.50%	8.00%	-68.50%	10.00%	55.10%	11.90%
Earnings Yield	1.16%	19.78%	-64.36%	1.44%	6.49%	-24.85%
FCF Yield	2.15%	19.70%	6.28%	-4.74%	-0.48%	-24.53%
Buyback Yield / Dilution	-2.85%	-6.23%	-0.34%	-	-77.64%	-82.73%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.